DK355489A - Anvendelse af substituerede 3,4-dihydro-2h-benzopyraner til fremstilling af et laegemiddel imod obstruktive funktionsforstyrrelser af lungerne og/eller forstyrrelser af urinafgangsvejene - Google Patents

Anvendelse af substituerede 3,4-dihydro-2h-benzopyraner til fremstilling af et laegemiddel imod obstruktive funktionsforstyrrelser af lungerne og/eller forstyrrelser af urinafgangsvejene Download PDF

Info

Publication number
DK355489A
DK355489A DK355489A DK355489A DK355489A DK 355489 A DK355489 A DK 355489A DK 355489 A DK355489 A DK 355489A DK 355489 A DK355489 A DK 355489A DK 355489 A DK355489 A DK 355489A
Authority
DK
Denmark
Prior art keywords
disorders
alkyl
dihydro
substituted
urinary
Prior art date
Application number
DK355489A
Other languages
English (en)
Other versions
DK355489D0 (da
DK171782B1 (da
Inventor
Heinrich Christian Englert
Erik Klaus
Dieter Mania
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK355489D0 publication Critical patent/DK355489D0/da
Publication of DK355489A publication Critical patent/DK355489A/da
Application granted granted Critical
Publication of DK171782B1 publication Critical patent/DK171782B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
DK355489A 1988-07-19 1989-07-18 Anvendelse af 3,4-dihydro-2H-benzo[b]pyraner til fremstilling af et lægemiddel imod obstruktive funktionsforstyrrelser af lungerne DK171782B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3824446A DE3824446A1 (de) 1988-07-19 1988-07-19 Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege
DE3824446 1988-07-19

Publications (3)

Publication Number Publication Date
DK355489D0 DK355489D0 (da) 1989-07-18
DK355489A true DK355489A (da) 1990-01-20
DK171782B1 DK171782B1 (da) 1997-05-26

Family

ID=6359009

Family Applications (1)

Application Number Title Priority Date Filing Date
DK355489A DK171782B1 (da) 1988-07-19 1989-07-18 Anvendelse af 3,4-dihydro-2H-benzo[b]pyraner til fremstilling af et lægemiddel imod obstruktive funktionsforstyrrelser af lungerne

Country Status (18)

Country Link
EP (2) EP0351720B1 (da)
JP (1) JPH0273015A (da)
KR (1) KR900001367A (da)
AT (1) ATE110270T1 (da)
AU (1) AU621388B2 (da)
CA (1) CA1336891C (da)
CZ (1) CZ417091A3 (da)
DE (2) DE3824446A1 (da)
DK (1) DK171782B1 (da)
ES (1) ES2061816T3 (da)
FI (1) FI893460A (da)
HU (1) HU210149B (da)
IE (1) IE63872B1 (da)
IL (1) IL91015A (da)
NZ (1) NZ229961A (da)
PH (1) PH26696A (da)
PT (1) PT91197B (da)
ZA (1) ZA895459B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW244350B (da) * 1991-12-14 1995-04-01 Hoechst Ag
TW316850B (da) * 1992-02-28 1997-10-01 Takeda Pharm Industry Co Ltd
HUT72741A (en) * 1992-12-19 1996-05-28 Alkaloida Vegyeszeti Gyar Method for producing benzopyrane derivatives and pharmaceutical compositions containing them
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
EP1244426A4 (en) * 1999-12-23 2004-10-06 Robert E Coifman METHODS AND FORMULATIONS FOR THE EFFICIENT ADMINISTRATION OF WATER-INSOLUBLE MEDICINES BY MEANS OF A NEBULIATOR
KR100475147B1 (ko) * 2002-09-09 2005-03-10 정의상 알루미나 분진 중의 유해가스 제거를 위한 탈취제 조성물
MXPA05004668A (es) 2002-11-12 2005-06-08 Warner Lambert Co Procedimiento de estimulacion de crecimiento de pelo usando benzopiranos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0107423B1 (en) * 1982-10-19 1986-07-23 Beecham Group Plc Novel chromans and chromenes
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
DE3881714D1 (de) * 1987-02-04 1993-07-22 Hoechst Ag Alkylsubstituierte n-benzopyranyllactame, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen

Also Published As

Publication number Publication date
AU621388B2 (en) 1992-03-12
PH26696A (en) 1992-09-15
DK355489D0 (da) 1989-07-18
DK171782B1 (da) 1997-05-26
PT91197A (pt) 1990-02-08
FI893460A (fi) 1990-01-20
EP0560399A1 (de) 1993-09-15
IE892323L (en) 1990-01-19
DE3824446A1 (de) 1990-01-25
NZ229961A (en) 1991-11-26
IE63872B1 (en) 1995-06-14
IL91015A (en) 1994-11-28
EP0351720A3 (de) 1992-01-02
KR900001367A (ko) 1990-02-27
HUT55988A (en) 1991-07-29
CZ417091A3 (en) 1993-02-17
PT91197B (pt) 1995-07-18
DE58908228D1 (de) 1994-09-29
FI893460A0 (fi) 1989-07-17
EP0351720B1 (de) 1994-08-24
ZA895459B (en) 1990-03-28
CA1336891C (en) 1995-09-05
HU210149B (en) 1995-02-28
ES2061816T3 (es) 1994-12-16
EP0351720A2 (de) 1990-01-24
AU3818989A (en) 1990-01-25
JPH0273015A (ja) 1990-03-13
ATE110270T1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
ES2037753T3 (es) Compuestos heterociclicos y su preparacion y uso.
DK355489A (da) Anvendelse af substituerede 3,4-dihydro-2h-benzopyraner til fremstilling af et laegemiddel imod obstruktive funktionsforstyrrelser af lungerne og/eller forstyrrelser af urinafgangsvejene
FI940414A0 (fi) Kinoliini- tai kinatsoliinijohdannaiset, niiden valmistus ja käyttö
ES2061518T3 (es) Compuestos que tienen propiedades antitumorales y antibacterianas.
IE880294L (en) Substituted 3,4-dihydro-2h-benzopyrans, process for their¹preparation, their use and pharmaceutical products based on¹these compounds
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
IE880295L (en) Alkyl-substitued n-benzopyranyllactams
ATE207479T1 (de) Kristalle von derivaten von chinozon carbonsäure- hydraten
DK0528164T3 (da) Anvendelse af xanthinderivater til fremstilling af et lægemiddel til behandling af sekundære nervecelleskader og funktionsforstyrrelser efter kranie-hjerne-traumer
DE58905079D1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
ATE30590T1 (de) Piperazin-derivate von theophyllin.
ES514553A0 (es) "un procedimiento para la preparacion de derivados piperacinicos de la teobromina".
TR26593A (tr) HIDROFIL DURUM GETIRILMIS TRIGLISERID'LERIN üRETILMESINE MAHSUS USUL.
ES2112867T3 (es) Sales de acidos acil-(2'-hidroxibifenil-2-il)-fosfinicos, su produccion y su utilizacion.
BR0215264A (pt) Compostos de oxazina fotocrÈmicos e métodos para a sua fabricação
DK42481A (da) Fremgangsmaade til fremstilling af piperazinderivater af theophyllin
ES2096800T3 (es) Benzo(b)tiofen-3-il-piperazinas, un procedimiento para su preparacion y su uso como medicamentos.
FI893099A (fi) Menetelmä lääkeaineena käyttökelpoisen glyserolijohdannaisen valmistamiseksi
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning
PT88234A (pt) Processo para a preparacao de derivados de cloroanilina
ATE101115T1 (de) Salicylate, ihre salze, diese enthaltende pharmazeutische kompositionen und ihr herstellungsverfahren.
DE69301639D1 (de) Tetrahydronaphtalenderivate, ihre Herstellung und ihre therapeutische Verwendung
SE8901570D0 (sv) Organic salts of cysteine derivatives
ATE95697T1 (de) Uricosuretische zusammensetzung.
IT1051359B (it) Eteri di benzodiossoli 2.2 diso stituiti

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK